62 related articles for article (PubMed ID: 19299041)
1. Dermatological Side Effects of Cancer Treatment: Psychosocial Implications-A Systematic Review of the Literature.
Almeida V; Pires D; Silva M; Teixeira M; Teixeira RJ; Louro A; Dinis MAP; Ferreira M; Teixeira A
Healthcare (Basel); 2023 Sep; 11(19):. PubMed ID: 37830658
[TBL] [Abstract][Full Text] [Related]
2. Impact of Skin Toxicities Associated with Targeted Cancer Therapies on Body Image: A Prospective Study.
Charles C; Razavi D; Bungener C; Mateus C; Lanoy E; Verschoore M; Dauchy S; Robert C
Clin Drug Investig; 2016 Mar; 36(3):235-42. PubMed ID: 26754775
[TBL] [Abstract][Full Text] [Related]
3. Barrier protective use of skin care to prevent chemotherapy-induced cutaneous symptoms and to maintain quality of life in patients with breast cancer.
Wohlrab J; Bangemann N; Kleine-Tebbe A; Thill M; Kümmel S; Grischke EM; Richter R; Seite S; Lüftner D
Breast Cancer (Dove Med Press); 2014; 6():115-22. PubMed ID: 25114589
[TBL] [Abstract][Full Text] [Related]
4. Toxic effects of multiple anticancer drugs on skin.
Kamil N; Kamil S; Ahmed SP; Ashraf R; Khurram M; Ali MO
Pak J Pharm Sci; 2010 Jan; 23(1):7-14. PubMed ID: 20067860
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy-induced iatrogenic injury of skin: new drugs and new concepts.
Choi JN
Clin Dermatol; 2011; 29(6):587-601. PubMed ID: 22014981
[TBL] [Abstract][Full Text] [Related]
6. [New drugs in oncology and skin toxicity].
Mateus C; Robert C
Rev Med Interne; 2009 May; 30(5):401-10. PubMed ID: 19299041
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous adverse effects of targeted therapies: Part I: Inhibitors of the cellular membrane.
Macdonald JB; Macdonald B; Golitz LE; LoRusso P; Sekulic A
J Am Acad Dermatol; 2015 Feb; 72(2):203-18; quiz 219-20. PubMed ID: 25592338
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of cutaneous toxicities to EGFR inhibitors.
Lacouture ME
Nat Rev Cancer; 2006 Oct; 6(10):803-12. PubMed ID: 16990857
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous side effects of epidermal growth factor receptor inhibitors: clinical presentation, pathogenesis, and management.
Hu JC; Sadeghi P; Pinter-Brown LC; Yashar S; Chiu MW
J Am Acad Dermatol; 2007 Feb; 56(2):317-26. PubMed ID: 17141360
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
